Familial hypercholesterolaemia trials in Czechia

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Taking people
  A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

  Where

  Brno, Prague, Prague 2

  Age

  6 years to 17 years

  People

  153 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07058077 · EU 2024-519068-42-00
• Phase 3Taking people
  Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

  Where

  Prague

  Age

  2 years to 100 years

  People

  195 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT05682378
• Phase 3Taking people
  Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  Where

  Prague

  Age

  6 years to 11 years

  People

  60 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06597019